Celesio Investors Hold Back Support For $5.5B McKesson Bid

By Karlee Weinmann (April 7, 2014, 3:25 PM EDT) -- California drugmaker McKesson Inc. said Monday that investors in German rival Celesio AG will have another two weeks to back its takeover play after they have so far proven slow to endorse the deal, which is worth about €4 billion ($5.5 billion), plus debt....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!